The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.EBI
Shandong University
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.EBI
University of Perugia
Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.EBI
Chiba University
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.EBI
Merck Research Laboratories
Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus.EBI
Merck Research Laboratories
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.EBI
Merck Research Laboratories
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.EBI
University of Tennessee Health Science Center
Control of hepatitis C: a medicinal chemistry perspective.EBI
University of Wollongong
Tetramic and tetronic acids: an update on new derivatives and biological aspects.EBI
University of Bayreuth
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.EBI
Biocon-Bristol Myers Squibb Research and Development Centre
Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.EBI
Bristol Myers Squibb Research and Early Development
Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAEBI
South China Agricultural University
Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.EBI
Imim/Universitat Pompeu Fabra
Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.EBI
Irbm, Mrl Rome
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.EBI
Shire Biochem
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.EBI
Shire Biochem
Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.EBI
Shire Biochem
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.EBI
Roche Discovery Welwyn
Glycine alpha-ketoamides as HCV NS3 protease inhibitors.EBI
Pharmaceutical Research Institute
Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.EBI
Irbm, Mrl Rome
Fragment-Based Identification of Influenza Endonuclease Inhibitors.EBI
University of California San Diego
SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease.EBI
University of California
Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease.EBI
Shionogi
Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity.EBI
Saint Petersburg State University
Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors.BDB
Irbm, Mrl Rome